Methes Energies International Ltd. (NASDAQ:MEIL) announced the pricing of its previously announced underwritten public offering. The Company is offering 2,500,000 registered shares of its common stock, par value $0.001 per share, at a price to the public of $2.00 per share. In connection with the offering, the Company has also granted the underwriter a 30-day option to purchase up to an additional 375,000 shares of common stock from the Company to cover over-allotments, if any. Methes Energies International Ltd. (NASDAQ:MEIL) net profit margin is -62.90% and weekly performance is -31.00%. On last trading day company shares ended up $2.07. Methes Energies International Ltd. (NASDAQ:MEIL) distance from 50-day simple moving average (SMA50) is -22.82%.
On 20 MAY LiveDeal Inc (NASDAQ:LIVE), announced its financial results for the three- month period that ended on March 31, 2014. Revenues increased by 22% year over year. Current cash position is $9,569,594 as of March 31, 2014, compared to $1,297,275 for the comparable quarter in 2013.Net Loss decreased by approximately 70%, year over year. Stockholders’ Equity increased by 275%, to $12,155,736 for the 2ndQ 2014 compared to $3,237,245 for the comparable quarter in 2013.LiveDeal Inc (NASDAQ:LIVE) shares fell -9.16% in last trading session and ended the day on $2.38. LIVE Gross Margin is 62.50% and its return on assets is -159.00%. LiveDeal Inc (NASDAQ:LIVE) quarterly performance is -74.55%.
Intermolecular Inc (NASDAQ:IMI) announced Monday morning that SanDisk and Toshiba have jointly elected to take an exclusive license, in a limited field, to Intermolecular’s rights in the intellectual property developed under the collaborative development program. Intermolecular Inc (NASDAQ:IMI) shares moved down -6.69% in last trading session and was closed at $2.65, while trading in range of $2.60 – $2.88. Intermolecular Inc (NASDAQ:IMI) year to date (YTD) performance is -46.14%.
Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported Q1 EPS of ($0.12), $0.04. Have made tremendous progress in 2014 based on the foundation we built in 2013. During this year, initiated clinical development of IMO-8400 in Waldenström’s macroglobulinemia and in diffuse large B-cell lymphoma (DLBCL) patients harboring the MYD88 L265P mutation. Idera Pharmaceuticals Inc (NASDAQ:IDRA) ended the last trading day at $2.44. Company weekly volatility is calculated as 7.81% and price to cash ratio as 6.84. Idera Pharmaceuticals Inc (NASDAQ:IDRA) showed a negative weekly performance of -7.58%.
Acorn Energy Inc (NASDAQ:ACFN) COO Joseph Musanti bought 3,000 shares of the stock in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $1.60 per share, with a total value of $4,800.00. Following the transaction, the chief operating officer now directly owns 9,200 shares in the company, valued at approximately $14,720. Acorn Energy Inc (NASDAQ:ACFN) weekly performance is -12.87%. On last trading day company shares ended up $1.49. Analysts mean target price for the company is $6.50. Acorn Energy Inc (NASDAQ:ACFN) distance from 50-day simple moving average (SMA50) is -45.66%.
Leave a Reply